다른 양성자 펌프 억제제에 교차반응이 없는 lansoprazole 아나필락시스 = Anaphylaxis to lansoprazole with tolerance to other proton pump inhibitors

다국어 초록 (Multilingual Abstract)

Anaphylaxis to proton pump inhibitors (PPIs) has rarely been reported. Different patterns of cross-reactivity between PPIs have also been demonstrated using skin tests. Here, we report a case of anaphylaxis to lansoprazole with tolerance to other commercially available PPIs, which was proved by skin tests and oral provocation tests (OPTs). A 47-year-old female patient visited our Emergency Department with a sudden onset of whole body urticaria, facial swelling, dyspnea, and loss of consciousness that developed 1 hour after ingestion of 30 mg of lansoprazole for her episodic epigastric soreness. The skin prick test (SPT) and the intradermal test (IDT) with lansoprazole, esomeprazole, rabeprazole, and pantoprazole were performed. Lansoprazole showed positive reactions in both the SPT (3 mg/mL) and the IDT (0.003 mg/mL). Rabeprazole (3 mg/mL) showed a positive reaction only in IDT. The SPT and the IDT with esomeprazole and pantoprazole were all negative. The OPT with 30 mg of lansoprazole was positive (showing generalized rash and facial swelling 30 minuites after ingestion), while OPTs with esomeprazole, pantoprazole, and rabeprazole were all negative. Other PPIs could be safe alternatives in cases of anaphylaxis to 1 PPI. Skin tests seem to be helpful to define cross-reactivity between PPIs.(Allergy Asthma Respir Dis 2014;2:383-386)

참고문헌 (Reference)

1 Sobrevia Elfau MT, "Study of cross-reactivity between proton pump inhibitors" 20 : 157-161, 2010

2 Kollmeier AP, "Recurrent anaphylaxis linked to pantoprazole" 114 : 975-977, 2004

3 Lobera T, "Nine cases of omeprazole allergy: cross-reactivity between proton pump inhibitors" 19 : 57-60, 2009

4 Choi SW, "Lessons from two cases of anaphylaxis to proton pump inhibitors" 37 : 614-616, 2012

5 Gremse DA, "Lansoprazole: pharmacokinetics, pharmacodynamics and clinical uses" 2 : 1663-1670, 2001

6 Kepil Ozdemir S, "Immediate-type hypersensitivity reactions to proton pump inhibitors: usefulness of skin tests in the diagnosis and assessment of cross-reactivity" 68 : 1008-1014, 2013

7 Vovolis V, "IgE-mediated anaphylaxis to proton pump inhibitors: cross-reacting study" 63 : 1251-1252, 2008

8 Bonadonna P, "Hypersensitivity to proton pump inhibitors: diagnostic accuracy of skin tests compared to oral provocation test" 130 : 547-549, 2012

9 Perez Pimiento AJ, "Hypersensitivity to lansoprazole and rabeprazole with tolerance to other proton pump inhibitors" 117 : 707-708, 2006

10 Chang YS, "Hypersensitivity reactions to proton pump inhibitors" 12 : 348-353, 2012

11 Bose S, "Evaluation and management of hypersensitivity to proton pump inhibitors" 111 : 452-457, 2013

12 Natsch S, "Anaphylactic reactions to proton-pump inhibitors" 34 : 474-476, 2000

13 Demirkan K, "Anaphylactic reaction to drugs commonly used for gastrointestinal system diseases: 3 case reports and review of the literature" 16 : 203-209, 2006

14 Garrido Fernandez S, "Allergy to proton pump inhibitors: diagnosis and assessment of cross-reactivity" 18 : 140-141, 2008

15 Porcel S, "Allergy to lansoprazole: study of cross-reactivity among proton-pump inhibitors" 60 : 1087-1088, 2005